Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies

Author:

de Oliveira Aldo S12ORCID,Valli Marilia2ORCID,Ferreira Leonardo LG2ORCID,Souza Julia M2ORCID,Krogh Renata2ORCID,Meier Lidiane1ORCID,Abreu Heitor R1ORCID,Voltolini Bruna G3ORCID,Llanes Luana C4ORCID,Nunes Ricardo J3ORCID,Braga Antonio L3ORCID,Andricopulo Adriano D2ORCID

Affiliation:

1. Federal University of Santa Catarina, Campus of Blumenau, Department of Exact Sciences & Education, Rua João Pessoa, 2750, Velha, Blumenau, SC, 89036-256, Brazil

2. University of Sao Paulo, Laboratory of Medicinal & Computational Chemistry, Center for Research & Innovation in Biodiversity & Drug Discovery, Institute of Physics of São Carlos, Av. João Dagnone, 1100, Santa Angelina, São Carlos, SP, 13563-120, Brazil

3. Federal University of Santa Catarina- Campus Florianopolis, Department of Chemistry, R. Eng. Agronômico Andrei Cristian Ferreira, s/n, Trindade, Florianópolis, SC, 88040-900, Brazil

4. Department of Chemistry & Biochemistry, University of California, Santa Barbara, CA 93106, USA

Abstract

Background: Chagas disease is a neglected tropical disease that affects millions of people worldwide and for which no effective treatment is available. Materials & methods: 17 chalcones were synthesized, for which the inhibition of cruzain and trypanocidal activity were investigated. Results: Chalcone C8 showed the highest cruzain inhibitory (IC50 = 0.536 μm) and trypanocidal activity (IC50 = 0.990 μm). Molecular docking studies showed interactions involving Asp161 and the thiophen group interacting with the S2 subsite. Furthermore, quantitative structure–activity relationship (q2 = 0.786; r2 = 0.953) and density functional theory studies were carried out, and a correlation between the lowest unoccupied molecular orbital surface and trypanocidal activity was observed. Conclusion: These results demonstrate that these chalcones are worthwhile hits to be further optimized in Chagas disease drug discovery programs.

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Reference36 articles.

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3